PharmaShots Weekly Snapshots (Mar 08 - 12, 2021)
Published: Mar 12, 2021 | Tags: PhaseBio, Signs, Supply, Agreement, BioVectra, Support, Development, Commercialization, Bentracimab
Published: Mar 12, 2021 | Tags: Takeda, Reports, NDA, Submission, Lanadelumab, MHLW, Preventive, Treatment, Hereditary Angioedema Attack, Japan
Sanofi and Translate Bio Initiate P-I/II Study of MRT5500 Against COVID-19
Published: Mar 12, 2021 | Tags: Sanofi and Translate Bio, Initiate, P-I/II, Study, MRT5500, Against, COVID-19
Abbott Launches Pandemic Defense Coalition to Detect Future Threats
Published: Mar 12, 2021 | Tags: Abbott, Launches, Pandemic Defense Coalition, Detect, Future, Threats
Published: Mar 12, 2021 | Tags: Astellas, Reports, NDA, Submission, Enfortumab Vedotin, MHLW, Locally, Advanced, Metastatic, Urothelial Cancer, Japan
Vir and GSK Report Results of VIR-7831 in P-III COMET-ICE Trial for COVID-19
Published: Mar 12, 2021 | Tags: Vir and GSK, Report, Results, VIR-7831, P-III COMET-ICE, Trial, COVID-19
Vertex's VX-880 Receives the US FDA's Fast Track Designation for T1D
Published: Mar 11, 2021 | Tags: Vertex, VX-880, Receives, US, FDA, Fast Track Designation, T1D
Lannett Receives the US FDA's Feedback for Development of Biosimilar Insulin Glargine
Published: Mar 11, 2021 | Tags: Lannett, Receives, US, FDA, Feedback, Development, Biosimilar Insulin Glargine
Published: Mar 11, 2021 | Tags: Roche, Actemra/RoActemra (tocilizumab), Veklury, Fail, Meet, Primary Endpoints, P-III REMDACTA, Study, Patients, Severe, COVID-19, Pneumonia
Published: Mar 11, 2021 | Tags: Empatica, Aura System, Receives, European, CE Mark, Detecting, Early Symptoms, COVID-19, Wearables
Grifols Acquires Remaining 56% of GigaGen for ~$80M
Published: Mar 11, 2021 | Tags: Grifols, Acquires, Remaining, 56%, GigaGen, ~$80M
Published: Mar 11, 2021 | Tags: Elli Lilly, Reports, Results, Bamlanivimab, Etesevimab, P-III BLAZE-1, Study, Prevention, COVID-19
Gilead Present Results of Lenacapavir in P-II/III CAPELLA Trial for the Treatment of HIV at CROI
Published: Mar 10, 2021 | Tags: Gilead, Present, Results, Lenacapavir, P-II/III CAPELLA, Trial, Treatment, HIV, CROI
SMA Foundation Collaborates with PTC to Discover and Develop Regenerative Medicine
Published: Mar 10, 2021 | Tags: SMA Foundation, Collaborates, PTC, Discover, Develop, Regenerative Medicine
Published: Mar 10, 2021 | Tags: Sorrento, Collaborates, Mount Sinai, Develop, Ab, Combination, Neutralizing, SARS-CoV-2, Emerging Variants, COVID-19
Published: Mar 10, 2021 | Tags: ViiV Healthcare, Presents, Results, GSK3640254 (GSK254), P-IIa study, Treatment, HIV, CROI
Novartis' Canakinumab Fails to Meet its Primary Endpoint in P-III CANOPY-2 Study
Published: Mar 10, 2021 | Tags: Novartis, Canakinumab, Fails, Meet, Primary Endpoint, P-III CANOPY-2, Study
Takeda to Acquire Maverick for ~$525M
Published: Mar 10, 2021 | Tags: Takeda, Acquire, Maverick, ~$525M
Published: Mar 9, 2021 | Tags: Exelixis, Signs, Exclusive, License, Agreement, WuXi Biologics, Expand, Growing, Oncology, Biologics, Pipeline
Published: Mar 9, 2021 | Tags: Roche, Ventana ALK (D5F3), CDx Assay, Receives, US, FDA, Approval, Treatment, ALK-Positive NSCLC
Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US
Published: Mar 9, 2021 | Tags: Abbott, Launches, NeuroSphere Virtual Clinic, Remote, Neurostim Programming, US
Published: Mar 9, 2021 | Tags: TrinamiX, Signs, Joint Development Agreement, VIAVI Solutions, Bring, Near-Infrared Spectroscopy, Smartphones
Lilly Collaborates with Biolojic to Discover and Develop Antibody Therapies for Diabetes
Published: Mar 9, 2021 | Tags: Lilly, Collaborates, Biolojic, Discover, Develop, Antibody, Therapies, Diabetes
Alteogen Reports Completion of P-I Study of ALT-L9 (biosimilar, aflibercept) in Korea
Published: Mar 9, 2021 | Tags: Alteogen, Reports, Completion, P-I Study, ALT-L9 (biosimilar, aflibercept), Korea
Atea Presents Results of AT-527 in P-I Study for COVID 19 at CROI
Published: Mar 8, 2021 | Tags: Atea, Presents, Results, AT-527, P-I Study, COVID 19
Kite's Yescarta Receives the US FDA's Approval for R/R Follicular Lymphoma
Published: Mar 8, 2021 | Tags: Kite, Yescarta, Receives, US, FDA, Approval, R/R Follicular Lymphoma
Gilead Presents Four-Year Data of Biktarvy for HIV-1 in Treatment-Naïve Adults at CROI 2021
Published: Mar 8, 2021 | Tags: Gilead, Presents, Four-Year Data, Biktarvy, HIV-1, Treatment, Naïve Adults
Roche to Withdraw Tecentriq Indication in Metastatic Bladder Cancer in the US
Published: Mar 8, 2021 | Tags: Roche, Withdraw, Tecentriq, Indication, Metastatic, Bladder Cancer US
Published: Mar 8, 2021 | Tags: Lee's Pharma, Initiate, P-III Trial, Socazolimab, 1L, Treatment, Extensive-stage Small-Cell Lung Cancer
Published: Mar 8, 2021 | Tags: ViiV Healthcare, Present, Results, Long- Acting, Cabotegravir, Rilpivirine, P-IIIb ATLAS-2M, Study, HIV
Related Post: PharmaShots Weekly Snapshots (Mar 01 - 05, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com